Latham & Watkins LLP represented the underwriters in the offering. Sigilon Therapeutics, Inc. (Nasdaq: SGTX) has announced its upsized initial public offering of 7,000,000 shares of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now